Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo

समान संसाधन

• IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations
  द्वारा: Vazquez-Martin, Alejandro, और अन्य
  प्रकाशित: (2013)
• Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin
  द्वारा: Corominas-Faja, Bruna, और अन्य
  प्रकाशित: (2013)
• Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs
  द्वारा: Corominas-Faja, Bruna, और अन्य
  प्रकाशित: (2012)
• The anti-malarial chloroquine overcomes Primary resistance and restores sensitivity to Trastuzumab in HER2-positive breast cancer
  द्वारा: Cufí, Sílvia, और अन्य
  प्रकाशित: (2013)
• Oncogenic miR-9 is a target of erlotinib in NSCLCs
  द्वारा: Chen, Xi, और अन्य
  प्रकाशित: (2015)